Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Chronic Renal Failure

Free Subscription Articles published in Lancet Retrieve available abstracts of 13 articles: HTML format

Single Articles

March 2024
1. WONG K, Pitcher D, Braddon F, Downward L, et al
   Effects of rare kidney diseases on kidney failure: a longitudinal analysis of the UK National Registry of Rare Kidney Diseases (RaDaR) cohort.
   Lancet. 2024;403:1279-1289.
   PubMed     Abstract available
   
   
   January 2024
2. KEARNEY N, Stefanovic N, Roche M
   Ultraviolet radiation manicure-related keratinocyte malignancies in a renal transplant recipient.
   Lancet. 2024;403:e1.
   PubMed    
   
   
   December 2023
3. TUTTLE KR, Hauske SJ, Canziani ME, Caramori ML, et al
   Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial.
   Lancet. 2023 Dec 15:S0140-6736(23)02408-X. doi: 10.1016/S0140-6736(23)02408.
   PubMed     Abstract available
   
   
   November 2023
4. HEERSPINK HJL, Kiyosue A, Wheeler DC, Lin M, et al
   Zibotentan in combination with dapagliflozin compared with dapagliflozin in patients with chronic kidney disease (ZENITH-CKD): a multicentre, randomised, active-controlled, phase 2b, clinical trial.
   Lancet. 2023 Nov 2:S0140-6736(23)02230-4. doi: 10.1016/S0140-6736(23)02230.
   PubMed     Abstract available
   
   
   
5. ROVIN BH, Barratt J, Heerspink HJL, Alpers CE, et al
   Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial.
   Lancet. 2023 Nov 2:S0140-6736(23)02302-4. doi: 10.1016/S0140-6736(23)02302.
   PubMed     Abstract available
   
   
   August 2023
6. HASSAN HA, Hafez MH, Luyckx VA, Tuglular S, et al
   Kidney failure in Sudan: thousands of lives at risk.
   Lancet. 2023;402:607.
   PubMed    
   
   
   March 2023
7. LUNDBERG S, Bergen K
   We can go further in non-immunosuppressive treatment of IgA nephropathy.
   Lancet. 2023 Mar 31:S0140-6736(23)00630-X. doi: 10.1016/S0140-6736(23)00630.
   PubMed    
   
   
   January 2023
8. BUDDE K, Halleck F
   Six pills less: no benefit for bicarbonate supplementation in renal allograft recipients.
   Lancet. 2023 Jan 25:S0140-6736(22)02630-7. doi: 10.1016/S0140-6736(22)02630.
   PubMed    
   
   
   
9. KOVALCHUK B, Khoramnia R
   Focusing on the eye signs of Alport syndrome in a 40-year-old man who previously had a kidney transplant and hearing loss.
   Lancet. 2023;401:e1.
   PubMed    
   
   
   November 2022
10. SELBY NM, Taal MW
    Evaluating the results of MyTEMP, a cluster randomised trial of lower temperature haemodialysis: the end of a cool idea?
    Lancet. 2022;400:1657-1659.
    PubMed    
    
    
    
11. MARK PB, Sattar N
    Implementation, not hesitation, for SGLT2 inhibition as foundational therapy for chronic kidney disease.
    Lancet. 2022 Nov 4. pii: S0140-6736(22)02164.
    PubMed    
    
    
    September 2022
12. FAUCON AL, Messai N, Pardon A
    A sweet unilateral pleural effusion: pleuro-peritoneal communication in a patient on dialysis.
    Lancet. 2022;400:920.
    PubMed    
    
    
    January 2022
13. TONELLI M, Thadhani R
    Anaemia in chronic kidney disease: what do new generation agents offer?
    Lancet. 2022 Jan 25. pii: S0140-6736(22)00120.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Chronic Renal Failure is free of charge.